Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Combined Therapy With Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage (SCEMPI)

NCT05617833 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05617833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Combined Therapy With Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage (SCEMPI)
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Recruiting
Start date
April 30, 2024
Completion date
September 30, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intraventricular hemorrhage of prematurity